Blood markers may outshine standard scores in sepsis prediction
NCT ID NCT07464054
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will enroll 61 adults with sepsis in the ICU to see if certain blood-based inflammatory and nutritional markers (like NLR, PLR, PNI, and SII) can predict death and disease severity more accurately than established clinical scores like SOFA and APACHE. Researchers will compare levels of these markers between patients who survive and those who do not. The goal is to find a simpler, faster way to identify high-risk sepsis patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors use simple blood tests to quickly predict which sepsis patients are at highest risk, potentially improving early treatment decisions.
What could go wrong
This is a small, early-stage observational study (61 people) that only looks at existing data. It won't test a new treatment, and results may not apply to all sepsis patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••